Related references
Note: Only part of the references are listed.Neuroendocrine Pulmonary Tumors of Low, Intermediate and High Grade: Anatomopathological Diagnosis-Prognostic and Predictive Factors
Jose Manuel Cameselle-Teijeiro et al.
MOLECULAR DIAGNOSIS & THERAPY (2018)
Neuroendocrine Tumors of the Lung: Current Challenges and Advances in the Diagnosis and Management of Well-Differentiated Disease
Andrew E. Hendifar et al.
JOURNAL OF THORACIC ONCOLOGY (2017)
Advances and Current Concepts in the Medical Management of Gastroenteropancreatic Neuroendocrine Neoplasms
Krystallenia I. Alexandraki et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Clinical presentation, diagnosis, and management of typical and atypical bronchopulmonary carcinoid
Hamza Hashmi et al.
JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY (2017)
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
M. E. Caplin et al.
ANNALS OF ONCOLOGY (2015)
The 2015 World Health Organization Classification of Lung Tumors Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification
William D. Travis et al.
JOURNAL OF THORACIC ONCOLOGY (2015)
Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors
M. Cives et al.
ENDOCRINE-RELATED CANCER (2015)
The molecular mechanisms and therapeutic potential of microRNA-7 in cancer
Dian-Na Gu et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2015)
Lin28b Promotes Head and Neck Cancer Progression via Modulation of the Insulin-Like Growth Factor Survival Pathway
Nehad M Alajez et al.
Oncotarget (2015)
Down-Regulation of miR-129-5p and the let-7 Family in Neuroendocrine Tumors and Metastases Leads to Up-Regulation of Their Targets Egr1, G3bp1, Hmga2 and Bach1
Kristina B. V. Dossing et al.
GENES (2015)
Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms
Eva Tiensuu Janson et al.
ACTA ONCOLOGICA (2014)
MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis
Naoya Sakamoto et al.
CANCER SCIENCE (2014)
Upstream and downstream mechanisms for the promoting effects of IGF-1 on differentiation of spermatogonia to primary spermatocytes
Guoqiu Shen et al.
LIFE SCIENCES (2014)
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Martyn E. Caplin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Correction: Recurrence of Early Stage Colon Cancer Predicted by Expression Pattern of Circulating microRNAs
Narayan Shivapurkar et al.
PLoS One (2014)
A two-microRNA signature as a potential biomarker for early gastric cancer
Guorong Zheng et al.
ONCOLOGY LETTERS (2014)
PI3K-AKT-mTOR-Signaling and beyond: the Complex Network in Gastroenteropancreatic Neuroendocrine Neoplasms
Franziska Briest et al.
THERANOSTICS (2014)
Targeting PI3K/Akt/mTOR signaling in cancer
Camillo Porta et al.
FRONTIERS IN ONCOLOGY (2014)
Inhibition of tumor promoting signals by activation of SSTR2 and opioid receptors in human breast cancer cells
Geetanjali Kharmate et al.
CANCER CELL INTERNATIONAL (2013)
MicroRNA-7-regulated TLR9 signaling-enhanced growth and metastatic potential of human lung cancer cells by altering the phosphoinositide-3-kinase, regulatory subunit 3/Akt pathway
Lin Xu et al.
MOLECULAR BIOLOGY OF THE CELL (2013)
Blockade of IGF-1R-not effective in neuroendocrine tumours
Steven K. Libutti
NATURE REVIEWS ENDOCRINOLOGY (2013)
microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis
N. Zhang et al.
ONCOGENE (2013)
MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor
X. Zhao et al.
ONCOGENE (2013)
Systemic Treatment in Unresectable Metastatic Well-Differentiated Carcinoid Tumors Consensus Results From a Modified Delphi Process
Jonathan R. Strosberg et al.
PANCREAS (2013)
A label-free, impedance-based real time assay to identify drug-induced toxicities and differentiate cytostatic from cytotoxic effects
S. Kustermann et al.
TOXICOLOGY IN VITRO (2013)
A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1
Qing Xu et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2013)
Pancreas-enriched miRNA refines endocrine cell differentiation
Sharon Kredo-Russo et al.
DEVELOPMENT (2012)
MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma
YuXiang Fang et al.
HEPATOLOGY (2012)
The Somatostatin Analogue Octreotide Inhibits Growth of Small Intestine Neuroendocrine Tumour Cells
Su-Chen Li et al.
PLOS ONE (2012)
How does Lin28 let-7 control development and disease?
James E. Thornton et al.
TRENDS IN CELL BIOLOGY (2012)
Prognostic significance of AKT/mTOR signaling in advanced neuroendocrine tumors treated with somatostatin analogs
Isabel Fernandes et al.
ONCOTARGETS AND THERAPY (2012)
Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms
Guenter Kloeppel
ENDOCRINE-RELATED CANCER (2011)
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
Marianne E. Pavel et al.
LANCET (2011)
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.
Eric Raymond et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Everolimus for Advanced Pancreatic Neuroendocrine Tumors.
James C. Yao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
MicroRNAs in Human Diseases: From Cancer to Cardiovascular Disease
Tai-You Ha
Immune Network (2011)
The Silencing of MicroRNA 148a Production by DNA Hypermethylation Is an Early Event in Pancreatic Carcinogenesis
Naima Hanoun et al.
CLINICAL CHEMISTRY (2010)
Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters
Martin B. Niederle et al.
ENDOCRINE-RELATED CANCER (2010)
Somatostatin and dopamine receptor interaction in prostate and lung cancer cell lines
M. Arvigo et al.
JOURNAL OF ENDOCRINOLOGY (2010)
Somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine tumours, current aspects and new perspectives
Marialuisa Appetecchia et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2010)
Functional Imaging of Neuroendocrine Tumors: A Head-to-Head Comparison of Somatostatin Receptor Scintigraphy, 123I-MIBG Scintigraphy, and 18F-FDG PET
Tina Binderup et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Mammalian microRNAs predominantly act to decrease target mRNA levels
Huili Guo et al.
NATURE (2010)
Robust one-day in situ hybridization protocol for detection of microRNAs in paraffin samples using LNA probes
Stine Jorgensen et al.
METHODS (2010)
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
Anja Rinke et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Inhibition of proliferation of small intestinal and bronchopulmonary neuroendocrine cell lines by using peptide analogs targeting receptors
Mark Kidd et al.
CANCER (2008)
Differential cytotoxicity of novel somatostatin and dopamine chimeric compounds on bronchopulmonary and small intestinal neuroendocrine tumor cell lines
Mark Kidd et al.
CANCER (2008)
Gastroenteropancreatic neuroendocrine tumours
Irvin M. Modlin et al.
LANCET ONCOLOGY (2008)
Quantitative gene expression of somatostatin receptors and noradrenaline transporter underlying scintigraphic results in patients with neuroendocrine tumors
Tina Binderup et al.
NEUROENDOCRINOLOGY (2008)
Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues
Heidi J. Peltier et al.
RNA (2008)
Characterization of the functional and growth properties of cell lines established from ileal and rectal carcinoid tumors
Gail A. Stilling et al.
ENDOCRINE PATHOLOGY (2007)
The development and characterization of a human midgut carcinoid cell line
George Van Buren et al.
CLINICAL CANCER RESEARCH (2007)
Treatment of gastroenteropancreatic neuroendocrine tumors
U. Ploeckinger et al.
VIRCHOWS ARCHIV (2007)
Survival from malignant digestive endocrine tumors in England and Wales: A population-based study
Come Lepage et al.
GASTROENTEROLOGY (2007)
Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathway
Corinne Bousquet et al.
EMBO JOURNAL (2006)
Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours
JK Ramage et al.
GUT (2005)
Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors -: A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis
M Papotti et al.
VIRCHOWS ARCHIV (2002)
Share Paper
